☆ 4.7 Article

Design and biological features of platinum (II) complexes with 3-hydroxy-3-(Trifluoromethyl)cyclobutane-1,1-Dicarboxylate as a leaving ligand

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Chemistry, Medicinal

Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore

Yuta Tanaka et al.

Summary: This study reports the discovery of novel brain-penetrant GCS inhibitors, which have the potential to treat Gaucher's disease and Parkinson's disease. The optimization of the structure and ADMETox profile resulted in the identification of T-036 as a potent GCS inhibitor in vivo. Scaffold hopping led to the development of another GCS inhibitor, T-690, with lower toxicological risk. The structural aspects of the compounds were discussed in terms of their unique inhibition mode and reduced cardiovascular risk.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Oncology

Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial

Shengxiang Ren et al.

Summary: This study demonstrates the effectiveness and safety of camrelizumab plus chemotherapy as a first-line treatment for advanced squamous NSCLC, with on-treatment ctDNA dynamics showing potential as a predictor of efficacy.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Design, synthesis and biological evaluation of antitumor platinum(II) agents conjugated with non-steroidal anti-inflammatory drug species

Ju Zang et al.

Summary: This study reported a series of novel platinum(II) complexes derived from conjugation of several NSAIDs derivatives with two antitumor platinum(II) agents, and evaluated their antitumor effects on multiple cancer cell lines. The compounds showed stronger antitumor activity compared to the parent platinum agents, with some even overcoming cisplatin resistance. One of the compounds, IA-1, exhibited the best cytotoxicity and surpassed cisplatin in terms of antitumor activity. Further research revealed that IA-1 induced significant DNA damage, ROS generation, and apoptosis in A2780 cells. IA-1 also inhibited metastasis and invasion of A2780 cells by suppressing the COX-2/JAK2/STAT3 axis. Overall, this study demonstrated that NSAIDs can enhance the activity of platinum(II) agents by inhibiting inflammation in cancer cells.

BIOORGANIC CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Medicinal

Design of a Potent, Selective, and Brain-Penetrant Inhibitor of Wnt-Deactivating Enzyme Notum by Optimization of a Crystallographic Fragment Hit

Nicky J. Willis et al.

Summary: Notum functions as a crucial enzyme in human diseases such as colorectal cancer and Alzheimer's disease. The discovery of 8l as a potent, selective, and brain-penetrant inhibitor of Notum activity suitable for oral dosing in rodent models of disease marks a significant progress in developing improved inhibitors for neurodegenerative diseases.

JOURNAL OF MEDICINAL CHEMISTRY (2022)

添加到收藏夹

Article Chemistry, Applied

Two Scalable Syntheses of 3-(Trifluoromethyl)cyclobutane-1-carboxylic Acid

Zhiguo J. Song et al.

Summary: Two efficient synthetic methods for preparing 3-(trifluoromethyl)cyclobutane-1-carboxylic acid are reported, starting from readily available 4-oxocyclobutane precursors. The bis-carboxylate system 9 can be deoxygenated and decarboxylated to provide the desired compound 1, while in the monocarboxylate system 15, the triflate can be efficiently eliminated followed by hydrogenation to yield cis-1.

ORGANIC PROCESS RESEARCH & DEVELOPMENT (2021)

添加到收藏夹

Article Chemistry, Medicinal

Ketoprofen and Loxoprofen Platinum(IV) Complexes Displaying Antimetastatic Activities by Inducing DNA Damage, Inflammation Suppression, and Enhanced Immune Response

Zuojie Li et al.

Summary: The study developed a ketoprofen platinum(IV) complex with potent anti-proliferative and anti-metastasis activities by inducing DNA damage and promoting apoptosis of tumor cells, thus inhibiting inflammation and metastasis.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Chemistry, Inorganic & Nuclear

Platinum(IV) antitumor complexes and their nano-drug delivery

Chunyan Jia et al.

Summary: This article summarizes the main problems of platinum-based anticancer drugs, introduces Pt-IV drugs and their characteristics, and focuses on the combination therapy with nanocarriers, looking forward to the application prospects of Pt-IV drugs and nanotechnology in the field of cancer chemotherapy.

COORDINATION CHEMISTRY REVIEWS (2021)

添加到收藏夹

Article Chemistry, Medicinal

Novel CK2-Specific Pt(II) Compound Reverses Cisplatin-Induced Resistance by Inhibiting Cancer Cell Stemness and Suppressing DNA Damage Repair in Non-small Cell Lung Cancer Treatments

Yuanjiang Wang et al.

Summary: The CK2 inhibitor HY1 was found to effectively inhibit cancer stem cells in non-small cell lung cancer (NSCLC), and a Pt(II) agent (HY1-Pt) was developed to reverse cisplatin-induced drug resistance. HY1-Pt targets CK2, suppresses DNA damage repair, enhances cellular accumulation of platinum, and inhibits CSCs through the Wnt/beta-catenin signal pathway. In vivo studies show that HY1-Pt has promising pharmacokinetics and higher tumor growth inhibitory efficacy with lower toxicity compared to cisplatin.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Article Chemistry, Medicinal

Structure-Activity Relationships of Triple-Action Platinum(IV) Prodrugs with Albumin-Binding Properties and Immunomodulating Ligands

Philipp Fronik et al.

Summary: The study introduces triple-action platinum(IV) prodrugs that target tumors through maleimide-mediated albumin binding and release the immunomodulatory ligand 1-MDT. The research reveals that the mode of 1-MDT conjugation significantly impacts the reducibility and activation of the prodrugs, affecting ligand release, pharmacokinetic properties, immunomodulation efficiency, and anticancer activity. This innovative strategy shows promise in enhancing the delivery of bioactive ligands and improving tumor-specific anticancer therapy.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

添加到收藏夹

Review Chemistry, Medicinal

Targeting drug delivery system for platinum(IV)-Based antitumor complexes

Yunshuang Zhong et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Platinum-Based Combination Therapy: Molecular Rationale, Current Clinical Uses, and Future Perspectives

Chunqiu Yu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A trifunctional Pt(II) complex alleviates the NHEJ/HR-related DSBs repairs to evade cisplatin-resistance in NSCLC

Xing Wang et al.

BIOORGANIC CHEMISTRY (2020)

添加到收藏夹

Article Chemistry, Medicinal

Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer

Maurizio Sabbatini et al.

JOURNAL OF MEDICINAL CHEMISTRY (2019)

添加到收藏夹

Article Oncology

A phase Ib/II study of HER3-targeting lumretuzumab in combination with carboplatin and paclitaxel as first-line treatment in patients with advanced or metastatic squamous non-small cell lung cancer

Juan-Miguel Cejalvo et al.

ESMO OPEN (2019)

添加到收藏夹

Article Chemistry, Medicinal

Fluorine and Fluorinated Motifs in the Design and Application of Bioisosteres for Drug Design

Nicholas A. Meanwell

JOURNAL OF MEDICINAL CHEMISTRY (2018)

添加到收藏夹

Article Chemistry, Multidisciplinary

Non-coordination planer cis-and trans-configuration of cis-[Pt(II)(mixed-NH3/RNH2)(3-OH-cyclobutane-1,1-dicarboxylate)]: separation, characterization, and anticancer activity

Jing Jiang et al.

RESEARCH ON CHEMICAL INTERMEDIATES (2018)

添加到收藏夹

Article Chemistry, Medicinal

A Drug of Such Damned Nature.1 Challenges and Opportunities in Translational Platinum Drug Research

Dorian M. Cheff et al.

JOURNAL OF MEDICINAL CHEMISTRY (2017)

添加到收藏夹

Review Chemistry, Multidisciplinary

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

Timothy C. Johnstone et al.

CHEMICAL REVIEWS (2016)

添加到收藏夹

Article Chemistry, Medicinal

Study on Antitumor Platinum(II) Complexes of Chiral Diamines with Dicyclic Species as Steric Hindrance

Fengfan Liu et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Chemistry, Medicinal

Applications of Fluorine in Medicinal Chemistry

Eric P. Gillis et al.

JOURNAL OF MEDICINAL CHEMISTRY (2015)

添加到收藏夹

Article Chemistry, Multidisciplinary

Potent Anticancer Activity and Possible Low Toxicity of Platinum(II) Complexes with Functionalized 1,1-Cyclobutanedicarboxylate as a Leaving Ligand

Jian Zhao et al.

CHEMISTRY-A EUROPEAN JOURNAL (2014)

添加到收藏夹

Article Chemistry, Medicinal

Platinum(II) complexes with N-monoalkyl 1R,2R-diaminocyclohexane derivatives as carrier ligands and 3-hydroxycyclobutane-1,1-dicarboxylate as a leaving group: Potent cytotoxicity and DNA binding ability

Lei Fang et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)

添加到收藏夹

Article Chemistry, Medicinal

In Vitro Anticancer Activity of cis-Diammineplatinum(II) Complexes with β-Diketonate Leaving Group Ligands

Justin J. Wilson et al.

JOURNAL OF MEDICINAL CHEMISTRY (2012)

添加到收藏夹

Article Chemistry, Physical

3-Hydroxycarboplatin, a Simple Carboplatin Derivative Endowed with an Improved Toxicological Profile

Weiping Liu et al.

PLATINUM METALS REVIEW (2012)

添加到收藏夹

Article Chemistry, Medicinal

Platinum-based antitumor drugs containing enantiomerically pure α-trifluoromethyl alanine as ligand

N Margiotta et al.

JOURNAL OF MEDICINAL CHEMISTRY (2005)

添加到收藏夹

Article Chemistry, Inorganic & Nuclear

Carboplatin derivatives with superior antitumor activity compared to the parent compound

G Bernhardt et al.

INORGANICA CHIMICA ACTA (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.